Porokeratosis Treatment Market 2021 company profiles, size, share

Posted by vinit sawant on February 4th, 2021

Porokeratosis is a keratinization disorder characterized by one or more atrophic macules surrounded by a distinctive hyperkeratotic, ridge-like border called a cornoid lamella.

It is estimated that the porokeratosis treatment market is expected to register a CAGR of 6.0% during the forecast period of 2018-2023.

Regional Analysis:

Asia Pacific is the fastest growing porokeratosis treatment market owing to a huge patient pool, increasing demand for treatments, and rising healthcare expenditure. In this region, the Mibelli type is most frequent as compared to other types. In Singapore, the Mibelli type of porokeratosis was present in 56% of porokeratosis patients in 2013, suggested by a study published in the Cases in Dermatology.

The Americas dominate the porokeratosis market owing to the rising prevalence of disseminated superficial actinic porokeratosis and increasing renal transplant cases, as around 10.68% of renal transplant recipients suffered from porokeratosis. According to the National Kidney Foundation, Inc., in 2014, 17,107 kidney transplants took place in the U.S. Moreover,advanced diagnostic and therapeutic solutions, high healthcare expenditure, and the presence of leading players are expected to boost the American porokeratosis treatment market.